Echo Therapeutics Inc (OTCMKTS:ECTE) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.02. Echo Therapeutics shares last traded at $0.02, with a volume of 28,694 shares traded.

The stock has a 50-day moving average price of $0.01.

About Echo Therapeutics (OTCMKTS:ECTE)

Echo Therapeutics, Inc engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union.

See Also: Profit margin is different from the revenue

Receive News & Ratings for Echo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Echo Therapeutics and related companies with's FREE daily email newsletter.